---
title: "FibroBiologics CEO to Present at BFC Global Healthcare Business Development and Investment Conference"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/271657750.md"
datetime: "2026-01-06T13:30:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271657750.md)
  - [en](https://longbridge.com/en/news/271657750.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271657750.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/271657750.md) | [繁體中文](https://longbridge.com/zh-HK/news/271657750.md)


# FibroBiologics CEO to Present at BFC Global Healthcare Business Development and Investment Conference

FibroBiologics Inc., a clinical-stage biotechnology company focused on developing therapeutics for chronic diseases using fibroblast technology, will present at the 9th Annual BFC Global Healthcare Business Development and Investment Conference. The presentation is scheduled for 4:30 p.m. PT on Sunday, January 11, 2026, at The St. Regis in San Francisco, California. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9620325-en) on January 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### 相关股票

- [Fibrobiologics (FBLG.US)](https://longbridge.com/zh-CN/quote/FBLG.US.md)

## 相关资讯与研究

- [FibroBiologics Announces Pricing of $3 Million Public Offering | FBLG Stock News](https://longbridge.com/zh-CN/news/281267970.md)
- [FibroBiologics Completes CYWC628 Manufacturing And Prices $3 Million Offering](https://longbridge.com/zh-CN/news/281340243.md)
- [EXCLUSIVE: FibroBiologics Moves Forward With Human Trial For Diabetic Foot Ulcer Therapy](https://longbridge.com/zh-CN/news/281237590.md)
- [FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis | FBLG Stock News](https://longbridge.com/zh-CN/news/271221955.md)
- [FibroBiologics raises $4M in gold-funded registered direct offering](https://longbridge.com/zh-CN/news/266576573.md)